Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing
- Author
- DE LA HOYA, Miguel1 ; OSORIO, Ana2 ; DEVILEE, Peter5 ; CALDES, Trinidad1 ; GODINO, Javier1 ; SULLEIRO, Sara1 ; TOSAR, Alicia1 ; PEREZ-SEGURA, Pedro3 ; FERNANDEZ, Cristina4 ; RODRIGUEZ, Raquel2 ; DIAZ-RUBIO, Eduardo3 ; BENITEZ, Javier2
[1] Laboratory of Molecular Oncology, Hospital Universitario San Carlos, Madrid, Spain
[2] National Center of Cancer (CNIO), Madrid, Spain
[3] Department of Medical Oncology, Hospital Universitario San Carlos, Madrid, Spain
[4] Department of Preventive Medicine, Hospital Universitario San Carlos, Madrid, Spain
[5] Department of Human and Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands - Source
International journal of cancer. = Journal international du cancer. 2002, Vol 97, Num 4, pp 466-471 ; ref : 36 ref
- CODEN
- IJCNAW
- ISSN
- 0020-7136
- Scientific domain
- Medical oncology
- Publisher
- Wiley-Liss, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Association Cancer familial Conseil génétique Dépistage Etude familiale Femelle Glande mammaire Gène suppresseur tumeur Génétique Homme Mutation Ovaire Phénotype Santé publique Tumeur maligne Gène BRCA1 Gène BRCA2 Espagne Appareil génital femelle pathologie Appareil génital femelle Glande mammaire pathologie Ovaire pathologie Europe
- Keyword (en)
- Association Familial cancer Genetic counseling Medical screening Family study Female Mammary gland Tumor suppressor gene Genetics Human Mutation Ovary Phenotype Public health Malignant tumor Spain Female genital diseases Female genital system Mammary gland diseases Ovarian diseases Europe
- Keyword (es)
- Asociación Cáncer familiar Consejo genético Descubrimiento Estudio familiar Hembra Glándula mamaria Gen supresor tumor Genética Hombre Mutación Ovario Fenotipo Salud pública Tumor maligno España Aparato genital hembra patología Aparato genital hembra Glándula mamaria patología Ovario patología Europa
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20C Female genital diseases / 002B20C02 Tumors
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13441919
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1002/ijc.1627 
https://dx.doi.org/10.1002/ijc.1627
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:16:\"10.1002\/ijc.1627\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: Implications for genetic testing\";s:9:\"\u0000*\u0000jtitle\";s:31:\"International journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:14:\"Int. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"97\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"466\";s:8:\"\u0000*\u0000epage\";s:3:\"471\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"DE LA HOYA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Miguel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"OSORIO, Ana\";i:1;s:14:\"DEVILEE, Peter\";i:2;s:16:\"CALDES, Trinidad\";i:3;s:14:\"GODINO, Javier\";i:4;s:14:\"SULLEIRO, Sara\";i:5;s:13:\"TOSAR, Alicia\";i:6;s:19:\"PEREZ-SEGURA, Pedro\";i:7;s:19:\"FERNANDEZ, Cristina\";i:8;s:17:\"RODRIGUEZ, Raquel\";i:9;s:19:\"DIAZ-RUBIO, Eduardo\";i:10;s:15:\"BENITEZ, Javier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: Implications for genetic testing\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:16:\"10.1002\/ijc.1627\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: Implications for genetic testing\";s:9:\"\u0000*\u0000jtitle\";s:31:\"International journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:14:\"Int. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"97\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"466\";s:8:\"\u0000*\u0000epage\";s:3:\"471\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"DE LA HOYA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Miguel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"OSORIO, Ana\";i:1;s:14:\"DEVILEE, Peter\";i:2;s:16:\"CALDES, Trinidad\";i:3;s:14:\"GODINO, Javier\";i:4;s:14:\"SULLEIRO, Sara\";i:5;s:13:\"TOSAR, Alicia\";i:6;s:19:\"PEREZ-SEGURA, Pedro\";i:7;s:19:\"FERNANDEZ, Cristina\";i:8;s:17:\"RODRIGUEZ, Raquel\";i:9;s:19:\"DIAZ-RUBIO, Eduardo\";i:10;s:15:\"BENITEZ, Javier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: Implications for genetic testing\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:16:\"10.1002\/ijc.1627\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:16:\"10.1002\/ijc.1627\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: Implications for genetic testing\";s:9:\"\u0000*\u0000jtitle\";s:31:\"International journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:14:\"Int. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"97\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"466\";s:8:\"\u0000*\u0000epage\";s:3:\"471\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"DE LA HOYA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Miguel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"OSORIO, Ana\";i:1;s:14:\"DEVILEE, Peter\";i:2;s:16:\"CALDES, Trinidad\";i:3;s:14:\"GODINO, Javier\";i:4;s:14:\"SULLEIRO, Sara\";i:5;s:13:\"TOSAR, Alicia\";i:6;s:19:\"PEREZ-SEGURA, Pedro\";i:7;s:19:\"FERNANDEZ, Cristina\";i:8;s:17:\"RODRIGUEZ, Raquel\";i:9;s:19:\"DIAZ-RUBIO, Eduardo\";i:10;s:15:\"BENITEZ, Javier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: Implications for genetic testing\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:16:\"10.1002\/ijc.1627\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: Implications for genetic testing\";s:9:\"\u0000*\u0000jtitle\";s:31:\"International journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:14:\"Int. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"97\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"466\";s:8:\"\u0000*\u0000epage\";s:3:\"471\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"DE LA HOYA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Miguel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"OSORIO, Ana\";i:1;s:14:\"DEVILEE, Peter\";i:2;s:16:\"CALDES, Trinidad\";i:3;s:14:\"GODINO, Javier\";i:4;s:14:\"SULLEIRO, Sara\";i:5;s:13:\"TOSAR, Alicia\";i:6;s:19:\"PEREZ-SEGURA, Pedro\";i:7;s:19:\"FERNANDEZ, Cristina\";i:8;s:17:\"RODRIGUEZ, Raquel\";i:9;s:19:\"DIAZ-RUBIO, Eduardo\";i:10;s:15:\"BENITEZ, Javier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: Implications for genetic testing\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:16:\"10.1002\/ijc.1627\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: Implications for genetic testing\";s:9:\"\u0000*\u0000jtitle\";s:31:\"International journal of cancer\";s:9:\"\u0000*\u0000stitle\";s:14:\"Int. j. cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"97\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"466\";s:8:\"\u0000*\u0000epage\";s:3:\"471\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"DE LA HOYA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Miguel\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:11:\"OSORIO, Ana\";i:1;s:14:\"DEVILEE, Peter\";i:2;s:16:\"CALDES, Trinidad\";i:3;s:14:\"GODINO, Javier\";i:4;s:14:\"SULLEIRO, Sara\";i:5;s:13:\"TOSAR, Alicia\";i:6;s:19:\"PEREZ-SEGURA, Pedro\";i:7;s:19:\"FERNANDEZ, Cristina\";i:8;s:17:\"RODRIGUEZ, Raquel\";i:9;s:19:\"DIAZ-RUBIO, Eduardo\";i:10;s:15:\"BENITEZ, Javier\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: Implications for genetic testing\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
